Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor in Children

NCT06470464 is registered in ClinicalTrials.gov with Shandong First Medical University as lead sponsor.

NCT NCT06470464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06470464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor in Children
Lead sponsor
Shandong First Medical University
Phase
Phase 2
Overall status
Completed
Start date
November 11, 2021
Completion date
June 16, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

germ cell tumor, yolk sac tumor